BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 496564)

  • 1. Types of cell-mediated immune response in invasive zone of carcinoma of the uterine cervix.
    Kozłowski H; Hrabowska M
    Arch Geschwulstforsch; 1979; 49(3):240-50. PubMed ID: 496564
    [No Abstract]   [Full Text] [Related]  

  • 2. Immunological analysis of Kenyan patients with advanced carcinoma of the cervix.
    Koech DK; Okello-Agina B; Iha DW
    East Afr Med J; 1984 Oct; 61(10):757-64. PubMed ID: 6336040
    [No Abstract]   [Full Text] [Related]  

  • 3. [Functional indices of the peripheral blood lymphocytes in gynecologic patients].
    Stepankovskaia GK; Senchuk AIa; Iarotskiĭ NE
    Vrach Delo; 1989 Oct; (10):81-3. PubMed ID: 2617996
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stages of development of immunologic response in the regional lymph nodes in invasive cancer of the uterine cervix.
    Kozlowski H; Hrabowska M
    Arch Geschwulstforsch; 1977; 47(6):550-60. PubMed ID: 607906
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell-mediated immunity in patients with invasive carcinoma of the cervix.
    Park TK; Kim SN
    Yonsei Med J; 1989; 30(2):164-72. PubMed ID: 2800566
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The composition of cellular interaction in the parablastomatous connective tissue in the stage I A and I B of cervical cancer.
    Kozłowski H; Hrabowska M
    Arch Geschwulstforsch; 1980; 50(7):676-85. PubMed ID: 6263210
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Cellular binding and differentiation in the immune response].
    Teodorescu M
    Microbiol Parazitol Epidemiol (Bucur); 1970; 15(2):97-112. PubMed ID: 4914386
    [No Abstract]   [Full Text] [Related]  

  • 8. Cell-mediated immunity in patients with tumors of the female genital tract.
    Zulli P
    Patol Clin Ostet Ginecol; 1977; 5(4):165-74. PubMed ID: 606604
    [No Abstract]   [Full Text] [Related]  

  • 9. A comparative study of the cellular immune response in patients with stage IB cervical squamous cell carcinoma. Low numbers of several immune cell subtypes are strongly associated with relapse of disease within 5 years.
    Nedergaard BS; Ladekarl M; Nyengaard JR; Nielsen K
    Gynecol Oncol; 2008 Jan; 108(1):106-11. PubMed ID: 17945335
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cellular immunity in carcinoma of the uterine cervix].
    Pasqualini RS; Giraudo Conesa LC; Chevallier R
    Medicina (B Aires); 1981; 41 Suppl():155-60. PubMed ID: 7345340
    [No Abstract]   [Full Text] [Related]  

  • 11. [Intact cellular immune response in patients with locally metastasizing breast carcinoma at the time of diagnosis].
    Ludwig C; Hartmann D; Landmann R; Wesp M; Rosenfelder G; Stucki D; Buser M; Obrecht JP
    Schweiz Med Wochenschr; 1983 Dec; 113(50):1908-11. PubMed ID: 6229873
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor-infiltrating lymphocytes contain higher numbers of type 1 cytokine expressors and DR+ T cells compared with lymphocytes from tumor draining lymph nodes and peripheral blood in patients with cancer of the uterine cervix.
    Santin AD; Ravaggi A; Bellone S; Pecorelli S; Cannon M; Parham GP; Hermonat PL
    Gynecol Oncol; 2001 Jun; 81(3):424-32. PubMed ID: 11371133
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Suppression of cellular immunity in patients with carcinoma in situ and microinvasive cancer of the cervix uteri].
    Marinova-Mutafchieva LP; Chakalova GB; Goranov IT
    Vopr Onkol; 1991; 37(4):454-7. PubMed ID: 1832253
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell-mediated cytotoxicity in preinvasive and invasive squamous cell carcinoma of the cervix.
    Dini MM; Jafari K; Faiferman I
    Obstet Gynecol; 1980 Jun; 55(6):728-31. PubMed ID: 7383460
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stereologic estimation of the total numbers, the composition and the anatomic distribution of lymphocytes in cone biopsies from patients with stage I squamous cell carcinoma of the cervix uteri.
    Nedergaard BS; Nielsen K; Nyengaard JR; Ladekarl M
    APMIS; 2007 Dec; 115(12):1321-30. PubMed ID: 18184401
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prospective malignancy grading of invasive squamous carcinoma of the uterine cervix. Prognostic significance in a long-term follow-up.
    Lindahl B; Ranstam J; Willén R
    Anticancer Res; 2007; 27(4C):2829-32. PubMed ID: 17695455
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Study of monocyte function in patients with cervical cancer by using T-lymphocyte monocyte interaction in response to phytohemagglutinin (author's transl)].
    Umesaki N; Nakade J; Nakamori H; Sako H; Lee T; Sugawa T
    Acta Obstet Gynaecol Jpn; 1981 May; 33(5):664-70. PubMed ID: 6972146
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Immunological status of cervical cancer patients].
    Il'in IV; Dekster LI; Letskiĭ VB
    Med Radiol (Mosk); 1979 Aug; 24(8):18-22. PubMed ID: 314558
    [No Abstract]   [Full Text] [Related]  

  • 19. Delayed cutaneous hypersensitivity reactions to membrane extracts of carcinomatous cells of the cervix uteri.
    Wells SA; Melewicz FC; Christiansen C; Ketcham AS
    Surg Gynecol Obstet; 1973 May; 136(5):717-20. PubMed ID: 4701902
    [No Abstract]   [Full Text] [Related]  

  • 20. [The cervix carcinoma as a tumor immunologic model. 1. Morphological and seroepidemiological studies].
    Koenig UD
    Fortschr Med; 1978 Sep; 96(33):1679-83. PubMed ID: 212355
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.